SMC green light for rare blood cancer treatment
NHS funding was backed for four medicines
Read More
Tag: lusutrombopag
Lusutrombopag gets EU green light for liver disease
Marketing authorisation in the EU has been granted for Shionogi’s lusutrombopag in severe thrombocytopenia.
Read More
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
